Provider
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Program effective Date: Aug 12, 2020
Documents & Forms Results
Displaying 2271 - 2280 of 3102 results
Provider
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Program effective Date: Aug 12, 2020
Provider
QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™
Program effective Date: Aug 12, 2020
Provider
QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM
Program effective Date: Aug 12, 2020
Provider
QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members
Program effective Date: Aug 12, 2020
Provider
P61-20 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Program effective Date: Aug 03, 2020
Provider
P58-20 Hereditary Angioedema (HAE) Drug Prior Authorization Management Changes for generic Icatibant, Firazyr, Haegarda, and Takhzyro — Effective October 5, 2020
Program effective Date: Aug 03, 2020
Provider
P56-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 5, 2020
Program effective Date: Aug 03, 2020
Provider
P59-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Aug 03, 2020
Provider
P60-20 Lab Management CPT Codes added by the American Medical Association (AMA) and eviCore Healthcare Specialty Utilization Management (UM) Program Updates
Program effective Date: Aug 03, 2020